974 related articles for article (PubMed ID: 17719739)
1. An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II. Testing of compounds.
Festag M; Viertel B; Steinberg P; Sehner C
Toxicol In Vitro; 2007 Dec; 21(8):1631-40. PubMed ID: 17719739
[TBL] [Abstract][Full Text] [Related]
2. Embryotoxicity hazard assessment of cadmium and arsenic compounds using embryonic stem cells.
Stummann TC; Hareng L; Bremer S
Toxicology; 2008 Oct; 252(1-3):118-22. PubMed ID: 18775467
[TBL] [Abstract][Full Text] [Related]
3. [Improving the embryonic stem cell test (EST) by establishing molecular endpoints of tissue specific development using murine embryonic stem cells (D3 cells)].
Seiler A; Visan A; Pohl I; Genschow E; Buesen R; Spielmann H
ALTEX; 2002; 19 Suppl 1():55-63. PubMed ID: 12096331
[TBL] [Abstract][Full Text] [Related]
4. Embryotoxicity hazard assessment of methylmercury and chromium using embryonic stem cells.
Stummann TC; Hareng L; Bremer S
Toxicology; 2007 Dec; 242(1-3):130-43. PubMed ID: 17980949
[TBL] [Abstract][Full Text] [Related]
5. Molecular multiple endpoint embryonic stem cell test--a possible approach to test for the teratogenic potential of compounds.
zur Nieden NI; Kempka G; Ahr HJ
Toxicol Appl Pharmacol; 2004 Feb; 194(3):257-69. PubMed ID: 14761682
[TBL] [Abstract][Full Text] [Related]
6. Development of prediction models for three in vitro embryotoxicity tests in an ECVAM validation study.
Genschow E; Scholz G; Brown N; Piersma A; Brady M; Clemann N; Huuskonen H; Paillard F; Bremer S; Becker K; Spielmann H
In Vitr Mol Toxicol; 2000; 13(1):51-66. PubMed ID: 10900407
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the embryotoxic potency of compounds in a newly revised high throughput embryonic stem cell test.
Peters AK; Steemans M; Hansen E; Mesens N; Verheyen GR; Vanparys P
Toxicol Sci; 2008 Oct; 105(2):342-50. PubMed ID: 18593728
[TBL] [Abstract][Full Text] [Related]
8. Trends in improving the embryonic stem cell test (EST): an overview.
Buesen R; Visan A; Genschow E; Slawik B; Spielmann H; Seiler A
ALTEX; 2004; 21(1):15-22. PubMed ID: 14976585
[TBL] [Abstract][Full Text] [Related]
9. Automated analysis of contractility in the embryonic stem cell test, a novel approach to assess embryotoxicity.
Peters AK; Wouwer GV; Weyn B; Verheyen GR; Vanparys P; Gompel JV
Toxicol In Vitro; 2008 Dec; 22(8):1948-56. PubMed ID: 18845236
[TBL] [Abstract][Full Text] [Related]
10. Use of two validated in vitro tests to assess the embryotoxic potential of mycophenolic acid.
Eckardt K; Stahlmann R
Arch Toxicol; 2010 Jan; 84(1):37-43. PubMed ID: 19856175
[TBL] [Abstract][Full Text] [Related]
11. An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. I: Establishment of the differentiation protocol.
Festag M; Sehner C; Steinberg P; Viertel B
Toxicol In Vitro; 2007 Dec; 21(8):1619-30. PubMed ID: 17723288
[TBL] [Abstract][Full Text] [Related]
12. First steps in establishing a developmental toxicity test method based on human embryonic stem cells.
Adler S; Pellizzer C; Hareng L; Hartung T; Bremer S
Toxicol In Vitro; 2008 Feb; 22(1):200-11. PubMed ID: 17961973
[TBL] [Abstract][Full Text] [Related]
13. Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test.
Seiler A; Visan A; Buesen R; Genschow E; Spielmann H
Reprod Toxicol; 2004; 18(2):231-40. PubMed ID: 15019721
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of novel high-throughput embryonic stem cell tests with new molecular markers for screening embryotoxic chemicals in vitro.
Suzuki N; Ando S; Yamashita N; Horie N; Saito K
Toxicol Sci; 2011 Dec; 124(2):460-71. PubMed ID: 21964422
[TBL] [Abstract][Full Text] [Related]
15. [Development of prediction models for three in vitro embryotoxicity tests which are evaluated in an ECVAM validation study].
Genschow E; Scholz G; Brown NA; Piersma AH; Brady M; Clemann N; Huuskonen H; Paillard F; Bremer S; Spielmann H
ALTEX; 1999; 16(2):73-83. PubMed ID: 11107310
[TBL] [Abstract][Full Text] [Related]
16. Specific effect of 5-fluorouracil on alpha-fetoprotein gene expression during the in vitro mouse embryonic stem cell differentiation.
Pamies D; Vicente-Salar N; Sogorb MA; Roche E; Reig JA
Int J Toxicol; 2010; 29(3):297-304. PubMed ID: 20448262
[TBL] [Abstract][Full Text] [Related]
17. Metabolic activation capacity by primary hepatocytes expands the applicability of the embryonic stem cell test as alternative to experimental animal testing.
Hettwer M; Reis-Fernandes MA; Iken M; Ott M; Steinberg P; Nau H
Reprod Toxicol; 2010 Aug; 30(1):113-20. PubMed ID: 20132877
[TBL] [Abstract][Full Text] [Related]
18. Embryotoxic potential of N-methyl-pyrrolidone (NMP) and three of its metabolites using the rat whole embryo culture system.
Flick B; Talsness CE; Jäckh R; Buesen R; Klug S
Toxicol Appl Pharmacol; 2009 Jun; 237(2):154-67. PubMed ID: 19281833
[TBL] [Abstract][Full Text] [Related]
19. The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. European Centre for the Validation of Alternative Methods.
Genschow E; Spielmann H; Scholz G; Seiler A; Brown N; Piersma A; Brady M; Clemann N; Huuskonen H; Paillard F; Bremer S; Becker K
Altern Lab Anim; 2002; 30(2):151-76. PubMed ID: 11971753
[TBL] [Abstract][Full Text] [Related]
20. Embryonic stem cell test: stem cell use in predicting developmental cardiotoxicity and osteotoxicity.
Kuske B; Pulyanina PY; zur Nieden NI
Methods Mol Biol; 2012; 889():147-79. PubMed ID: 22669664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
